Have a personal or library account? Click to login
Ruthenium(II) Complexes as Potential Apoptosis Inducers in Cancer Therapy Cover

Ruthenium(II) Complexes as Potential Apoptosis Inducers in Cancer Therapy

EABR. Experimental and Applied Biomedical Research
Volume 25 (2024): Issue 1 (March 2024)
By: Radica Zivkovic Zaric,  Marijana Stanojevic Pirkovic and  Nedim Hamzagic  
Open Access
|Apr 2024

Authors

Radica Zivkovic Zaric

radica_zivkovic@yahoo.com

University of Kragujevac, Faculty of Medical Sciences, Department of Pharmacology and Toxicology, Kragujevac, Serbia

Marijana Stanojevic Pirkovic

University of Kragujevac, Faculty of Medical Sciences, Department of Biochemistry, Kragujevac, Serbia

Nedim Hamzagic

Center of Hemodialysis, Medical Center Tutin, Serbia
DOI: https://doi.org/10.2478/sjecr-2019-0016 | Journal eISSN: 2956-2090 | Journal ISSN: 2956-0454
Journal RSS Feed
Language: English
Page range: 71 - 79
Submitted on: Feb 5, 2019
|
Accepted on: Mar 26, 2019
|
Published on: Apr 11, 2024
Published by: University of Kragujevac, Faculty of Medical Sciences
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
Ruthenium complexes,
apoptosis,
cancer therapy
Related subjects:
Medicine,
Clinical medicine,
Clinical medicine, other

© 2024 Radica Zivkovic Zaric, Marijana Stanojevic Pirkovic, Nedim Hamzagic, published by University of Kragujevac, Faculty of Medical Sciences
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous articleVolume 25 (2024): Issue 1 (March 2024)Next article